NCT05901012View on ClinicalTrials.gov

Safety and Tolerability of DMT in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions
Safety IssuesHealthy Volunteers
Interventions
DRUG

N,N-Dimethyltryptamine

DMT will be administered using a vaporizer device in a placebo-controlled, double-blind, randomized, monocentric clinical trial design.

DRUG

Placebo

DMT will be administered using a vaporizer device in a placebo-controlled, double-blind, randomized, monocentric clinical trial design.

Trial Locations (1)

59012300

Hospital Universitário Onofre Lopes, Natal

All Listed Sponsors
lead

Universidade Federal do Rio Grande do Norte

OTHER